mRNA– tag –
-
mRNA-LNP Technology Proven Effective in COVID-19 Vaccines, Bolstering Drug Delivery Customization Capabilities
Inside Therapeutics USA Overview This article discusses the revolutionary potential of mRNA-lipid nanoparticles (LNPs) in pharmaceuticals, vaccines, and therapeutics. LNPs are highlighted as the most clinically advanced platform for mRNA... -
Cleavable Crosslinking of Cholesterol Stabilizes Anionic mRNA Lipid Nanoparticles, Enhancing Splenic mRNA Expression and Transfection Efficiency
ACS Applied Materials & Interfaces (ACS Publications) USA Overview This study introduces a novel method to stabilize anionic mRNA lipid nanoparticles (LNPs) through cleavable crosslinking of cholesterol, addressing stability limitations ... -
Cytiva Webinar Unpacks mRNA-LNP Innovations Driving Next-Gen Cancer Vaccines and Scalable Manufacturing
Cytiva Sweden Overview A forthcoming Cytiva webinar is set to explore the latest advancements in mRNA-LNP (Lipid Nanoparticle) technology, critical for accelerating next-generation cancer vaccine development. The discussion will focus on... -
Beyond RNA: DNA-Guided CRISPR Heralds a New Era of Precision Gene Editing
Liv Hospital Turkey Overview Liv Hospital reports a significant shift in CRISPR gene editing, moving from conventional RNA-guided to potentially more stable and precise DNA-guided systems. This evolution, coupled with advancements in del... -
Thermo Fisher Scientific Explains How PAT Enables Real-Time Quality Control in Pharmaceutical Manufacturing, With AI Transforming Data into Actionable Insights
Thermo Fisher Scientific (Behind the Bench) USA Overview Thermo Fisher Scientific elucidates how Process Analytical Technology (PAT) facilitates real-time quality control across diverse pharmaceutical modalities, including biologics, mRN... -
GEMMABio Secures ARPA-H Funding to Advance LNP-Delivered mRNA Base Editing Strategy for Rare Liver Diseases
BioSpace USA Overview GEMMABio announced securing ARPA-H funding to develop four mRNA-encoded base editing products delivered via lipid nanoparticles (LNPs) in collaboration with Profluent. This innovative strategy targets four pathogeni... -
MSC-Derived Exosomes Emerge as Promising Cell-Free Regenerative Therapies, Driving Active Research in Arthritis, Chronic Wounds, and Inflammatory Diseases
Vertex AI Search USA Overview Mesenchymal Stem Cell (MSC)-derived exosomes are garnering significant attention in regenerative medicine as a cell-free therapeutic alternative, capable of delivering MSCs' potent regenerative and immunomod... -
Future of RNA Manufacturing: AI and Continuous Processing to Boost IVT Efficiency, Reduce Production Costs, and Facilitate Distributed Production
(Industry analysis/expert opinion) International Overview The future of RNA manufacturing is set to be optimized by integrating artificial intelligence (AI) and machine learning with continuous processes across all stages, from IVT effic... -
Porton Advanced Fortifies End-to-End ATMP CDMO Services with Over 250 Global Clients
Porton Advanced China Overview Porton Advanced is strengthening its end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), serving over 250 global customers. The company offers cell engineering CMC services for autolo... -
Biologics Outsourcing Redefined: Modality Expertise & End-to-End Integration Key for Partnerships
Bioprocess Online USA Overview Biologics manufacturing outsourcing is evolving into strategic partnerships focused on modality expertise, regulatory excellence, and end-to-end integration, moving beyond mere cost savings. To support incr...
